Shop

Showing 913–928 of 1319 results

Article: O01 SPATIAL ORGANIZATION OF THE IMMUNE MICROENVIRONMENT AFTER NEOADJUVANT TREATMENT OF BREAST CANCER
€3.03 Add to cart
Article: O02 IMMUNE-RELATED ADVERSE EVENTS: A SINGLE-CENTRE RETROSPECTIVE ANALYSIS IN A REAL-WORLD SCENARIO
€3.03 Add to cart
Article: O03 SJÖGREN’S SYNDROME INDUCED BY IMMUNE CHECKPOINT INHIBITORS: CASE REPORT OF TWO PATIENTS AND REVIEW OF THE LITERATURE
€3.03 Add to cart
Article: O04 MICROENVIRONMENT-MEDIATED LIPID METABOLISM REPROGRAMMING AND ANTI-EGFR THERAPY RESISTANCE IN HEAD AND NECK SQUAMOUS CELL CARCINOMA
€3.03 Add to cart
Article: O05 DETECTION OF CIRCULATING TUMOR DNA (CTDNA) POST NEOADJUVANT CHEMOTHERAPY (NACT) USING A PERSONALIZED ASSAY IN PATIENTS (PTS) WITH EARLY BREAST CANCER (EBC) IS ASSOCIATED WITH DISEASE RELAPSE
€3.03 Add to cart
Article: O06 EMOTIONAL FREEDOM TECHNIQUES AS AN EFFECTIVE STRATEGY FOR TREATMENT OF SELF-REPORTED CANCER-RELATED COGNITIVE IMPAIRMENT IN CANCER SURVIVORS (EMOTICON)
€3.03 Add to cart
Article: O07 PREDICT UNDERESTIMATES SURVIVAL OF PATIENTS (PTS) WITH HER2-POSITIVE (HER2+) EARLY-STAGE BREAST CANCER (EBC)
€3.03 Add to cart
Article: O08 CETUXIMAB: AN EFFECTIVE TREATMENT OF VULVAR SQUAMOUS CELL CARCINOMA
€3.03 Add to cart
Article: Oligometastatic ovarian cancer successfully treated with stereotactic radiotherapy
€3.03 Add to cart
Article: Oncological highlights from the World Conference on Lung Cancer 2024
€3.03 Add to cart
Article: Oncological topics presented at EAU 2018
€3.03 Add to cart
Article: Oncology highlights of the EAU20 Virtual Congress and EAU20 Theme Week
€3.03 Add to cart
Article: One in a million
€3.03 Add to cart
Article: Operational Risk Management (ORM): the aviation safety model can be transposed into the medical sector
€3.03 Add to cart
Article: Opinions of lung cancer patients on tobacco advertising and smoking in public places
€3.03 Add to cart
Article: Opportunities and challenges in oncology and molecular testing: the Belgian strategy
€3.03 Add to cart

Article: O01 SPATIAL ORGANIZATION OF THE IMMUNE MICROENVIRONMENT AFTER NEOADJUVANT TREATMENT OF BREAST CANCER

Article: O02 IMMUNE-RELATED ADVERSE EVENTS: A SINGLE-CENTRE RETROSPECTIVE ANALYSIS IN A REAL-WORLD SCENARIO

Article: O03 SJÖGREN’S SYNDROME INDUCED BY IMMUNE CHECKPOINT INHIBITORS: CASE REPORT OF TWO PATIENTS AND REVIEW OF THE LITERATURE

Article: O04 MICROENVIRONMENT-MEDIATED LIPID METABOLISM REPROGRAMMING AND ANTI-EGFR THERAPY RESISTANCE IN HEAD AND NECK SQUAMOUS CELL CARCINOMA

Article: O05 DETECTION OF CIRCULATING TUMOR DNA (CTDNA) POST NEOADJUVANT CHEMOTHERAPY (NACT) USING A PERSONALIZED ASSAY IN PATIENTS (PTS) WITH EARLY BREAST CANCER (EBC) IS ASSOCIATED WITH DISEASE RELAPSE

Article: O06 EMOTIONAL FREEDOM TECHNIQUES AS AN EFFECTIVE STRATEGY FOR TREATMENT OF SELF-REPORTED CANCER-RELATED COGNITIVE IMPAIRMENT IN CANCER SURVIVORS (EMOTICON)

Article: O07 PREDICT UNDERESTIMATES SURVIVAL OF PATIENTS (PTS) WITH HER2-POSITIVE (HER2+) EARLY-STAGE BREAST CANCER (EBC)

Article: O08 CETUXIMAB: AN EFFECTIVE TREATMENT OF VULVAR SQUAMOUS CELL CARCINOMA

Article: Oligometastatic ovarian cancer successfully treated with stereotactic radiotherapy

Article: Oncological highlights from the World Conference on Lung Cancer 2024

Article: Oncological topics presented at EAU 2018

Article: Oncology highlights of the EAU20 Virtual Congress and EAU20 Theme Week

Article: One in a million

Article: Operational Risk Management (ORM): the aviation safety model can be transposed into the medical sector

Article: Opinions of lung cancer patients on tobacco advertising and smoking in public places

Article: Opportunities and challenges in oncology and molecular testing: the Belgian strategy